These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12768941)

  • 1. Plasma homocysteine and arterial thromboembolic disease.
    Mbewu AD; Nogoduka C; Taylor B
    S Afr Med J; 2003 Mar; 93(3):192-4. PubMed ID: 12768941
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease.
    Fermo I; Vigano' D'Angelo S; Paroni R; Mazzola G; Calori G; D'Angelo A
    Ann Intern Med; 1995 Nov; 123(10):747-53. PubMed ID: 7574192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alternative view of homocysteine.
    Dudman NP
    Lancet; 1999 Dec; 354(9195):2072-4. PubMed ID: 10636386
    [No Abstract]   [Full Text] [Related]  

  • 4. Homocysteine levels and peripheral arterial occlusive disease: a prospective cohort study and review of the literature.
    Asfar S; Safar HA
    J Cardiovasc Surg (Torino); 2007 Oct; 48(5):601-5. PubMed ID: 17989630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Don't forget homocystéinemia's screening in young patients with arterial thrombosis].
    Lellouche F; Dorval I; Corvisier JM; Geffroy F; Rouaut G
    Rev Med Interne; 2006 Jan; 27(1):77-8. PubMed ID: 16274874
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperhomocysteinemia and thrombosis: an overview.
    Eldibany MM; Caprini JA
    Arch Pathol Lab Med; 2007 Jun; 131(6):872-84. PubMed ID: 17550314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia is common in patients with antiphospholipid syndrome and may contribute to expression of major thrombotic events.
    Avivi I; Lanir N; Hoffman R; Brenner B
    Blood Coagul Fibrinolysis; 2002 Mar; 13(2):169-72. PubMed ID: 11914660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methionine-loading and random homocysteine tests have no added value in risk assessment for venous and arterial thrombosis.
    Lijfering WM; Veeger NJ; Brouwer JL; van de Poel MH; van der Meer J
    J Thromb Haemost; 2007 Mar; 5(3):614-6. PubMed ID: 17181828
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine and arterial occlusive disease: a concise review.
    Andreotti F; Burzotta F; Mazza A; Manzoli A; Robinson K; Maseri A
    Cardiologia; 1999 Apr; 44(4):341-5. PubMed ID: 10371785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
    Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperhomocysteinemia, a risk factor for atherosclerosis: causes and effects].
    Weiss N; Pietrzik K; Keller C
    Dtsch Med Wochenschr; 1999 Sep; 124(38):1107-13. PubMed ID: 10535040
    [No Abstract]   [Full Text] [Related]  

  • 13. Are B vitamins a risk factor for venous thromboembolism? Yes.
    Eichinger S
    J Thromb Haemost; 2006 Feb; 4(2):307-8. PubMed ID: 16420555
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum homocysteine concentrations in children with inflammatory bowel disease.
    Eren M; Nur Saltik-Temizel I; Koçak N
    J Pediatr Gastroenterol Nutr; 2004 Aug; 39(2):215-6. PubMed ID: 15269637
    [No Abstract]   [Full Text] [Related]  

  • 15. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?
    Oldenburg B; Fijnheer R; van der Griend R; vanBerge-Henegouwen GP; Koningsberger JC
    Am J Gastroenterol; 2000 Oct; 95(10):2825-30. PubMed ID: 11051355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are B vitamins a risk factor for VTE? Perhaps.
    den Heijer M
    J Thromb Haemost; 2006 Feb; 4(2):309-11. PubMed ID: 16420556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance.
    Boers GH
    Thromb Haemost; 1997 Jul; 78(1):520-2. PubMed ID: 9198207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine and risk for atherothrombotic events.
    Puddu P
    Cardiologia; 1999 Jul; 44(7):627-31. PubMed ID: 10476587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial marker proteins in hyperhomocysteinemia.
    de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
    Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderate hyperhomocysteinemia and cardiovascular disease.
    Tsai MY
    J Lab Clin Med; 2000 Jan; 135(1):16-25. PubMed ID: 10638690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.